Lisa Carron Shmerling

Keine laufenden Positionen mehr

63 Jahre

Health Technology

Consumer Services

Profil

Lisa Carron Shmerling has been Vice President-Legal Affairs of Momenta Pharmaceuticals, Inc. since March 2006.
From April 2005 to February 2006, she was Deputy General Counsel of Momenta Pharmaceuticals and a Legal Consultant from September 2003 to March 2005.
From 1998 to 2003, Ms. Shmerling was an Associate General Counsel of Millennium Pharmaceuticals, Inc. She received a BSW degree from The State University of New York and a JD from the New England School of Law.

Ehemalige bekannte Positionen von Lisa Carron Shmerling

Unternehmen	Position	Ende
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	General Counsel	01.01.2003
MOMENTA PHARMACEUTICALS, INC.	General Counsel	-

Sehen Sie sich die Erfahrung von Lisa Carron Shmerling im Detail an

Ausbildung von Lisa Carron Shmerling

State University of New York at Albany	Undergraduate Degree
Southern New England School of Law	Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Lisa Carron Shmerling im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology